ExtrAperitoneaL Plasty vs Intraperitoneal oNlay mEsh in Ventral Hernia Repair
Conditions: Ventral Hernia; Abdominal Wall Defect Interventions: Procedure: Extended totally extraperitoneal repair; Procedure: Intraperitoneal onlay mesh Sponsors: University Hospital, Basel, Switzerland; St. Clara Hospital, Basel, Switzerland; Innklinikum Alt ötting, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Implementation of Liquid Biopsies During Routine Clinical Care in Patients With Advanced Malignancies (LIQPLAT)
Conditions: Advanced Solid Tumor Interventions: Diagnostic Test: ctDNA measurement Sponsors: University Hospital, Basel, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience Basel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias
Conditions: Ventral Hernia; Incisional Hernia; Abdominal Wall Defect Interventions: Procedure: Robotically-assisted ventral hernia repair (RVHR); Procedure: Open ventral hernia repair (OVHR) Sponsors: University Hospital, Basel, Switzerland; St. Clara Hospital, Basel, Switzerland; Klinikum Kempten, Kempten, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
Conditions: Triple-negative Breast Cancer; TNBC - Triple-Negative Breast Cancer Interventions: Drug: INT230-6; Other: neoadjuvant immuno-chemotherapy Sponsors: Swiss Group for Clinical Cancer Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.
Conditions: Acute Aortic Dissection; Thoracic Aortic Aneurysm Sponsors: University Hospital, Basel, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study
Conditions: Castration-resistant Prostate Cancer Interventions: Drug: Injection, 161Tb-SibuDAB,1GBq; Drug: Injection, 177Lu-PSMA-I&T, 1GBq; Drug: Injection, 161Tb-SibuDAB, Dose Escalation Sponsors: University Hospital, Basel, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Mental Imagery and Targeted Memory Reactivation in Insomnia
Conditions: Insomnia Disorder Interventions: Behavioral: Imagery Rescripting (IR); Behavioral: Imagery Rescripting (IR) and Targeted Memory Reactivation (TMR) during sleep; Behavioral: Sleep Hygiene; Behavioral: Sleep Hygiene + Odor; Other: " Rocking bed " if patients still have insomnia complaints (ISI>10) after the 4 weeks of the intervention Sponsors: University Hospital, Geneva; University of Geneva, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Mesenteric Infiltration in Ovarian Cancer
Conditions: Ovary Cancer Interventions: Diagnostic Test: Computed Tomography Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Danube University Krems; Institut du Cancer de Montpellier - Val d ' Aurelle; Ente Ospedaliero Cantonale, Ticino, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Administration of Intranasal Midazolam for Anxiety in Palliative Care
Conditions: Anxiety; Acute Anxiety Interventions: Drug: Placebo Nasal Spray 0 mg/spray; Drug: Midazolam Nasal Spray 0.45 mg/spray; Drug: Midazolam Nasal Spray 0.9 mg/spray Sponsors: Insel Gruppe AG, University Hospital Bern; University Hospital, Basel, Switzerland; University Hospital, Z ürich; Stadtspital Zürich Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Zirconia Implants: Practice-based Evidence
Conditions: Dental Implants; Ceramic Implant Interventions: Procedure: Immediate dental implants placements on fresh sockets after tooth extraction Sponsors: Swiss Dental Solutions; VISTA Institute for Therapeutic Innovations Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2
Conditions: Multiple Sclerosis Sponsors: University Hospital, Basel, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Magnetic Resonance Imaging of Cognitive Deficits in the Brain of Individuals With Spinal Cord Injury
Conditions: Spinal Cord Injury Sponsors: Swiss Paraplegic Research, Nottwil Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Use of Facility Ratings to Improve Satisfaction With Heath Care for Children
Conditions: Low Quality Health Care for Children Interventions: Behavioral: Quality ratings of health care providers for children Sponsors: Swiss Tropical& Public Health Institute; Lao Tropical and Public Health Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Pupillometric Evaluation in Patients Declared Brain Dead - a Prospective Quality Control Study
Conditions: Brain Death; Adults Interventions: Diagnostic Test: non-invasive device-supported, automated pupillometry Sponsors: University Hospital, Basel, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
Conditions: Follicular Lymphoma Interventions: Drug: Mosunetuzumab; Drug: Lenalidomide; Drug: Rituximab; Drug: Obinutuzumab; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristin; Drug: Prednisone; Drug: Rituximab; Drug: Obinutuzumab; Drug: Bendamustin Sponsors: The Lymphoma Academic Research Organisation; Lymphoma Study Association; Swiss Group for Clinical Cancer Research; Grupo Espa ñol de Linfomas y Transplante Autólogo de Médula Ósea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
